Evidence map›Paper›PMID 20465544›Full record

ArticleThe Biochemical journal2010

Loss of AMP-activated protein kinase alpha2 subunit in mouse beta-cells impairs glucose-stimulated insulin secretion and inhibits their sensitivity to hypoglycaemia.

Craig Beall, Kaisa Piipari, Hind Al-Qassab, Mark A Smith, Nadeene Parker, David Carling, Benoit Viollet, Dominic J Withers, Michael L J Ashford

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Leptin-induced Trafficking of KInternational journal of molecular sciences · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Oleate induces KNeuroscience · 2017
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Craig BeallBiomedical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK.
Kaisa Piipari
Hind Al-Qassab
Mark A Smith
Nadeene Parker
David Carling
Benoit Viollet
Dominic J Withers
Michael L J Ashford
Centre National de la Recherche Scientifique · FR

Funding

Biotechnology and Biological Sciences Research Council BB/H020527/2Medical Research Council G0600316Medical Research Council G0600866Medical Research Council MC_U120027537Medical Research Council MC_U120097114Wellcome Trust 068692Wellcome Trust 073073
6 · The paper itself

Abstract

AMPK (AMP-activated protein kinase) signalling plays a key role in whole-body energy homoeostasis, although its precise role in pancreatic beta-cell function remains unclear. In the present study, we therefore investigated whether AMPK plays a critical function in beta-cell glucose sensing and is required for the maintenance of normal glucose homoeostasis. Mice lacking AMPK alpha2 in beta-cells and a population of hypothalamic neurons (RIPCre alpha2KO mice) and RIPCre alpha2KO mice lacking AMPK alpha1 (alpha1KORIPCre alpha2KO) globally were assessed for whole-body glucose homoeostasis and insulin secretion. Isolated pancreatic islets from these mice were assessed for glucose-stimulated insulin secretion and gene expression changes. Cultured beta-cells were examined electrophysiologically for their electrical responsiveness to hypoglycaemia. RIPCre alpha2KO mice exhibited glucose intolerance and impaired GSIS (glucose-stimulated insulin secretion) and this was exacerbated in alpha1KORIPCre alpha2KO mice. Reduced glucose concentrations failed to completely suppress insulin secretion in islets from RIPCre alpha2KO and alpha1KORIPCre alpha2KO mice, and conversely GSIS was impaired. Beta-cells lacking AMPK alpha2 or expressing a kinase-dead AMPK alpha2 failed to hyperpolarize in response to low glucose, although KATP (ATP-sensitive potassium) channel function was intact. We could detect no alteration of GLUT2 (glucose transporter 2), glucose uptake or glucokinase that could explain this glucose insensitivity. UCP2 (uncoupling protein 2) expression was reduced in RIPCre alpha2KO islets and the UCP2 inhibitor genipin suppressed low-glucose-mediated wild-type mouse beta-cell hyperpolarization, mimicking the effect of AMPK alpha2 loss. These results show that AMPK alpha2 activity is necessary to maintain normal pancreatic beta-cell glucose sensing, possibly by maintaining high beta-cell levels of UCP2.

Indexed as

Adenosine TriphosphateAMP-Activated Protein KinasesAnimalsGlucokinaseGlucoseGlucose Transporter Type 2HomeostasisHypoglycemiaHypothalamusInsulinInsulin-Secreting CellsInsulin SecretionIn Vitro TechniquesIon ChannelsMembrane PotentialsMiceAdenosine TriphosphateAMP-Activated Protein KinasesGlucokinaseGlucoseGlucose Transporter Type 2InsulinIon ChannelsMitochondrial ProteinsPrkaa1 protein, mousePrkaa2 protein, mouseSlc2a2 protein, mouseUcp2 protein, mouseUcp2 protein, ratUncoupling Protein 2

Identifiers

PMID20465544
PMCPMC2895783
OpenAlexW2050149324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.